# Randomized Double-blind Clinical Trial With L.Reuteri Supplementation in Children With Autism Spectrum Disorder

> **NCT04293783** · NA · COMPLETED · sponsor: **University of Rome Tor Vergata** · enrollment: 43 (actual)

## Conditions studied

- Autism Spectrum Disorder

## Interventions

- **DIETARY_SUPPLEMENT:** L.Reuteri
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT04293783
- **Lead sponsor:** University of Rome Tor Vergata
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-01
- **Primary completion:** 2020-10-30
- **Final completion:** 2021-08-30
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2023-11-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04293783

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04293783, "Randomized Double-blind Clinical Trial With L.Reuteri Supplementation in Children With Autism Spectrum Disorder". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04293783. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*